Literature DB >> 25016026

Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.

Deepa Rajasekaran1, Swen Zierow1, Mansoor Syed2, Richard Bucala3, Vineet Bhandari2, Elias J Lolis4.   

Abstract

We report a new inflammatory activity for extracellular d-dopachrome tautomerase (D-DT), the recruitment of neutrophils to the lung on D-DT intratracheal installation of C57BL/6J mice with an EC50 of 5.6 μg. We also find that D-DT and macrophage migration inhibitory factor (MIF) have additive effects in neutrophil recruitment. Although the tautomerase site of D-DT and its homologue MIF are biophysically very different, 4-iodo-6-phenylpyrimidine (4-IPP) forms a covalent bond with Pro-1 of both proteins, resulting in a 6-phenylpyrimidine (6-PP) adduct. Recruitment of neutrophils to the lung for the 6-PP adducts of D-DT and MIF are reduced by ∼ 50% relative to the apo proteins, demonstrating that an unmodified Pro-1 is important for this activity, but there is no cooperativity in inhibition of the proteins together. The differences in the binding mode of the 6-PP adduct for D-DT was determined by crystallographic studies at 1.13 Å resolution and compared to the structure of the MIF-6-PP complex. There are major differences in the location of the 6-PP adduct to the D-DT and MIF active sites that provide insight into the lack of cooperativity by 4-IPP and into tuning the properties of the covalent inhibitors of D-DT and MIF that are necessary for the development of therapeutic small molecules against neutrophil damage from lung infections such as Pseudomonas aeruginosa in cystic fibrosis and immunocompromised patients. © FASEB.

Entities:  

Keywords:  4-IPP; covalent inhibitor

Mesh:

Substances:

Year:  2014        PMID: 25016026      PMCID: PMC4200328          DOI: 10.1096/fj.14-256636

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  56 in total

1.  Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.

Authors:  Yoonsang Cho; Gregg V Crichlow; Jon J Vermeire; Lin Leng; Xin Du; Michael E Hodsdon; Richard Bucala; Michael Cappello; Matt Gross; Federico Gaeta; Kirk Johnson; Elias J Lolis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-08       Impact factor: 11.205

2.  Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening.

Authors:  Larry R McLean; Ying Zhang; Hua Li; Ziyu Li; Ulrike Lukasczyk; Yong-Mi Choi; Zuoning Han; Joy Prisco; Jeremy Fordham; Joseph T Tsay; Stephan Reiling; Roy J Vaz; Yi Li
Journal:  Bioorg Med Chem Lett       Date:  2009-10-01       Impact factor: 2.823

3.  Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism.

Authors:  Barry J Plant; Charles G Gallagher; Richard Bucala; John A Baugh; Sally Chappell; Linda Morgan; Clare M O'Connor; Kevin Morgan; Seamas C Donnelly
Journal:  Am J Respir Crit Care Med       Date:  2005-09-22       Impact factor: 21.405

4.  Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site.

Authors:  Larry R McLean; Ying Zhang; Hua Li; Yong-Mi Choi; Zuoning Han; Roy J Vaz; Yi Li
Journal:  Bioorg Med Chem Lett       Date:  2010-02-06       Impact factor: 2.823

5.  Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.

Authors:  Zoe Cournia; Lin Leng; Sunilkumar Gandavadi; Xin Du; Richard Bucala; William L Jorgensen
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

6.  Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.

Authors:  Stephanie E Brock; Beatriz E Rendon; Kavitha Yaddanapudi; Robert A Mitchell
Journal:  J Biol Chem       Date:  2012-09-17       Impact factor: 5.157

7.  Isolation of a new tautomerase monitored by the conversion of D-dopachrome to 5,6-dihydroxyindole.

Authors:  G Odh; A Hindemith; A M Rosengren; E Rosengren; H Rorsman
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

8.  Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion.

Authors:  Alvaro Arjona; Harald G Foellmer; Terrence Town; Lin Leng; Courtney McDonald; Tian Wang; Susan J Wong; Ruth R Montgomery; Erol Fikrig; Richard Bucala
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Macrophage CD74 contributes to MIF-induced pulmonary inflammation.

Authors:  Koichiro Takahashi; Kiyokazu Koga; Helena M Linge; Yinzhong Zhang; Xinchun Lin; Christine N Metz; Yousef Al-Abed; Kaie Ojamaa; Edmund J Miller
Journal:  Respir Res       Date:  2009-05-04

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  25 in total

1.  Structural Plasticity in the C-Terminal Region of Macrophage Migration Inhibitory Factor-2 Is Associated with an Induced Fit Mechanism for a Selective Inhibitor.

Authors:  Georgios Pantouris; Richard Bucala; Elias J Lolis
Journal:  Biochemistry       Date:  2018-06-12       Impact factor: 3.162

2.  A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity.

Authors:  Pathricia Veronica Tilstam; Georgios Pantouris; Michael Corman; Monica Andreoli; Keyvan Mahboubi; Gary Davis; Xin Du; Lin Leng; Elias Lolis; Richard Bucala
Journal:  J Biol Chem       Date:  2019-10-02       Impact factor: 5.157

3.  Disentangling the effects of tocilizumab on neutrophil survival and function.

Authors:  Timo Gaber; Martin Hahne; Cindy Strehl; Paula Hoff; Yvonne Dörffel; Eugen Feist; Gerd-Rüdiger Burmester; Frank Buttgereit
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 4.  Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Joshua B Bilsborrow; Edward Doherty; Pathricia V Tilstam; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2019-08-20       Impact factor: 6.902

5.  Regulation of MIF Enzymatic Activity by an Allosteric Site at the Central Solvent Channel.

Authors:  Georgios Pantouris; Leepakshi Khurana; Anthony Ma; Erin Skeens; Krystle Reiss; Victor S Batista; George P Lisi; Elias J Lolis
Journal:  Cell Chem Biol       Date:  2020-05-19       Impact factor: 8.116

Review 6.  The non-mammalian MIF superfamily.

Authors:  Amanda Sparkes; Patrick De Baetselier; Kim Roelants; Carl De Trez; Stefan Magez; Jo A Van Ginderachter; Geert Raes; Richard Bucala; Benoît Stijlemans
Journal:  Immunobiology       Date:  2016-10-12       Impact factor: 3.144

Review 7.  Role of macrophage migration inhibitory factor in age-related lung disease.

Authors:  Maor Sauler; Richard Bucala; Patty J Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-08       Impact factor: 5.464

Review 8.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

9.  Reduced Osteoarthritis Severity in Aged Mice With Deletion of Macrophage Migration Inhibitory Factor.

Authors:  Meredith A Rowe; Lindsey R Harper; Margaret A McNulty; Anthony G Lau; Cathy S Carlson; Lin Leng; Richard J Bucala; Richard A Miller; Richard F Loeser
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

10.  D-dopachrome tautomerase activates COX2/PGE2 pathway of astrocytes to mediate inflammation following spinal cord injury.

Authors:  Huiyuan Ji; Yuxin Zhang; Chen Chen; Hui Li; Bingqiang He; Ting Yang; Chunshuai Sun; Huifei Hao; Xingyuan Zhang; Yingjie Wang; Yue Zhou; Zhenjie Zhu; Yuming Hu; Aihong Li; Aisong Guo; Yongjun Wang
Journal:  J Neuroinflammation       Date:  2021-06-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.